Randomized, double-blind, multi-center, phase III clinical trial to evaluate the immunogenicity and safety of MG1109 (egg-based pre-pandemic influenza A/H5N1 vaccine) in healthy adults

• Hoofdauteurs: Joon Young Song (Auteur), Min Joo Choi (Auteur), Ji Yun Noh (Auteur), Won Suk Choi (Auteur), Hee Jin Cheong (Auteur), Seong-Heon Wie (Auteur), Jin-Soo Lee (Auteur), Gyu-Jin Woo (Auteur), Sang Ho Lee (Auteur), Woo Joo Kim (Auteur)
• Formaat: Boek
• Gepubliceerd in: Taylor & Francis Group, 2017-05-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Considering the pandemic potential of avian influenza A/H5N1, development of an effective and well-tolerated vaccine is an essential part of pandemic preparedness plans. This phase III, randomized, double-blind study was conducted to assess the immunogenicity and safety profile of an alum-adjuvanted...